当前位置: 首页 > 期刊 > 《中国医药导报》 > 2016年第8期
编号:1598839
霉酚酸酯在临床上的应用进展
http://www.100md.com 2016年5月14日 中国医药导报 2016年第8期
     王慧娟 陈永刚 邹吉利

    [摘要] 随着现代医学的发展,霉酚酸酯(MMF)作为一种强效低毒的免疫抑制剂越来越受到关注。霉酚酸酯与其他免疫抑制剂比较,具有毒副作用小、选择性强、感染复发率低等优势。霉酚酸酯还有多种药理活性,不仅用于肾脏、心脏、肺、肝等器官的移植,对自身免疫性疾病、皮肤病及眼科疾病都有很好的治疗作用。本文结合国内外发表的相关文章,对霉酚酸酯的药代动力学研究、器官移植、自身免疫性疾病、皮肤病等几个方面进行综述,为进一步开发利用霉酚酸酯提供理论依据。

    [关键词] 霉酚酸酯;移植;免疫抑制剂;临床应用

    [中图分类号] R967;R969 [文献标识码] A [文章编号] 1673-7210(2016)03(b)-0036-04

    [Abstract] With the development of modern medicine, MMF was paid more attention to, which was a sufficient immunosuppressant with minimal toxicity. Compared with other immunosuppressants, MMF has an advantages of small side effects, strong selectivity and low infection recurrence rate. MMF has a variety of pharmacological activities, which is not only efficient for the kidney, heart, lung and liver transplantations, but also useful for autoimmune diseases, skin diseases and eye diseases.This paper combines the relevant articles which have published in both local and abroad to review the pharmacokinetics, organ transplantation, autoimmune diseases and skin diseases, which can provide a theoretical for the further development and utilization of mycophenolate. ......

您现在查看是摘要页,全文长 13361 字符